Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousPeripheral Blood Stem Cell TransplantationMultiple MyelomaTransplantation ConditioningMelphalanCombined Modality TherapyBone Marrow TransplantationTreatment OutcomeStem CellsAntineoplastic Combined Chemotherapy ProtocolsRemission InductionSalvage TherapyHematopoietic Stem Cell MobilizationLymphoma, Non-HodgkinDisease-Free SurvivalHodgkin DiseaseRecurrenceEtoposideCarmustineLiver TransplantationCyclophosphamideMyeloablative AgonistsGraft vs Host DiseaseBone Marrow PurgingCytarabineHematopoietic Stem CellsSurvival RateGraft SurvivalHematologic NeoplasmsWhole-Body IrradiationVincristineAntigens, CD34Survival AnalysisRetrospective StudiesThiotepaBusulfanKidney TransplantationDexamethasoneLymphoma, Mantle-CellLeukapheresisGranulocyte Colony-Stimulating FactorAmyloidosisCell TransplantationFollow-Up StudiesPrognosisThalidomideAntibodies, Monoclonal, Murine-DerivedBoronic AcidsPyrazinesAntineoplastic Agents, AlkylatingTime FactorsDoxorubicinMesenchymal Stem Cell TransplantationTransplantation ChimeraLymphoma, FollicularPrednisoneAutograftsTissue DonorsLymphomaLymphoma, T-Cell, PeripheralNeoplasm, ResidualCord Blood Stem Cell TransplantationHeart TransplantationCell DifferentiationLeukemia, Myeloid, AcuteIfosfamideImmunosuppressive AgentsLung TransplantationPodophyllotoxinMyelodysplastic SyndromesAntineoplastic AgentsIdarubicinBlood Component RemovalHematopoiesisInduction ChemotherapyLymphoma, Large B-Cell, DiffuseBone MarrowEmbryonic Stem CellsMaintenance ChemotherapyBone Marrow CellsHistocompatibility TestingFeasibility StudiesAdult Stem CellsTransplantation ImmunologyOrgan TransplantationGraft RejectionCells, CulturedProspective StudiesBlood Transfusion, AutologousEnteropathy-Associated T-Cell LymphomaLymphoma, B-CellAntibodies, MonoclonalLeukemiaLeukemia, Plasma CellInfusions, SpinalGraft vs Tumor EffectMitoxantrone